Robert Hilkert

机构：Merck & Co., Inc., Rahway, NJ, USA (United States) · ORCID：0000-0001-6952-2649

发表论文 50 篇 · 总被引 2079 次 · h-index 15

代表论文

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017 · The Lancet · 被引 1343)
The relationship between renal impairment and left ventricular structure, function, and ventricular–arterial interaction in hypertension (2011 · Journal of Hypertension · 被引 29)
Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease (2014 · Journal of Hypertension · 被引 24)
Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension (2011 · Journal of Clinical Hypertension · 被引 23)
Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States (2023 · JACC Heart Failure · 被引 22)
Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis (2021 · Journal of Cardiac Failure · 被引 19)